Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 2.1 Agreement and Plan of Merger, Dated June 17, 2020.
- 3.1 Certificate of Merger
- 3.2 Amended and Restated Certificate of Incorporation
- 3.3 Amended and Restated Bylaws
- 10.1 2020 Stock Option and Incentive Plan
- 10.2 2020 Senior Executive Cash Incentive Bonus Plan
- 10.3 Offer Letter, Dated November 8, 2017, Between Vered Bisker-leib and Compass Therapeutics LLC
- 10.4 Form of Indemnification Agreement (Directors)
- 10.5 Form of Indemnification Agreement (Executive Officers)
- 10.6 Form of Pre-merger Indemnification Agreement (Directors and Executive Officers)
- 10.7 Registration Rights Agreement, Dated June 19, 2020.
- 10.8 Subscription Agreement, Dated June 19, 2020.
- 10.9 Amended and Restated Collaboration Agreement, Dated February 11, 2015.
- 10.10 Loan and Security Agreement, Dated March 30, 2018.
- 10.11 First Amendment to Loan and Security Agreement, Dated September 26, 2018.
- 10.12 Second Amendment to Loan and Security Agreement, Dated March 8, 2019.
- 10.13 Third Amendment to Loan and Security Agreement, Dated October 29, 2019.
- 10.14 Sublease Agreement, Dated July 29, 2016.
- 10.15 Sublease Modification Agreement, Dated January 17, 2018.
- 16.1 Letter from Raich Ende Malter & Co. LLP
- 21.1 Subsidiaries of the Registrant
- 99.1 Audited Financial Statements of Compass Therapeutics, LLC As of and for the Fiscal Years Ended December 31, 2019 and 2018
- 99.2 Unaudited Financial Statements of Compass Therapeutics, LLC As of and for the Quarterly Period Ended March 31, 2020
- 99.3 Unaudited Pro Forma Combined Financial Statements As of and for the Fiscal Year Ended December 31, 2019
- 99.4 Press Release Dated June 23, 2020
CMPX similar filings
Filing view
External links